(Q44202981)

30 November 2017

New-onset diabetes and ketoacidosis with atypical antipsychotics (English)

1 reference

30 November 2017

1 reference

Daniel R Wilson

1

1 reference

30 November 2017

Leo D'Souza

2

1 reference

30 November 2017

Nibar Sarkar

3

1 reference

30 November 2017

Michael Newton

4

1 reference

30 November 2017

Connie Hammond

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

30 November 2017

Schizophrenia Research

1 reference

30 November 2017

59

1 reference

30 November 2017

1

1 reference

30 November 2017

1-6

1 reference

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Risperidone-associated diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Psychotropic drugs, diabetes and chronic mental patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

New onset diabetes and atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Atypical antipsychotics and hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Diabetes mellitus in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Glucose-induced increase in memory performance in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Blood Sugar Levels in Patients Treated with Chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

New-onset diabetes mellitus associated with the initiation of quetiapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

The effect of age on the association between body-mass index and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Phenothiazines and Diabetes in Hospitalized Women

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

Novel antipsychotics and new onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900331-0

7 January 2021

10.1016/S0920-9964(01)00331-0

Identifiers

DOI

1 reference

30 November 2017

1 reference